A skilled and experienced organization
PledPharma’s organization is small, but it is experienced and effective, has a knowledge-intensive network and has unique, integrated drug development expertise.
Substantial expertise in the entire drug development chain
A new management team was appointed in 2017 with the remit ofcreating the optimum conditions to further develop its drug candidates. The company’s in-house expertise has been reinforced, and this expertise is solid throughout the entire value chain, from early clinical development to successful registration of drug candidates. The company’s employees have extensive collective experience in preclinical and clinical pharmaceutical drug development, strategic regulatory expertise (regulatory affairs with the FDA, EMA and PMDA), financing and investments (understanding of investors’ demands for a sustainable business), CMC (chemistry manufacturing and control of the active drug substance), planning and project management of clinical studies, purchasing, project management and cooperation with partners such as API (active pharmaceutical ingredient) manufacturers, CROs (contract research organizations) and patenting.
In addition to expertise and experience, flexibility and good teamwork are needed to successfully carry out complex pharmaceutical drug development. The company’s employees are organized into cross-functional teams that enable a holistic view and greater opportunities to take the development projects all the way to the end.
At the beginning of 2019, PledPharma had nine employees. The Company also engages consultants and partners when there is a need for specific expertise.
An organization with clear values
PledPharma is a small organization with the flexibility that this allows. Its work is also based on the following values:
- We are results-driven, with clear goals and a high level of ethics.
- We work as a team that cooperates cross functionally with one another and our partners, where we take advantage of our extensive expertise and experience.
- We are brave and challenge the status quo.